Nvidia's positions in these companies were relatively small at the end of the third quarter of 2025, but the chipmaker has spent recent years building a portfolio of AI‑related investments across ...

If you are leasing a car, what’s the point of paying thousands of dollars due at lease signing? My contract says tax, title, fees and licensing — but then wouldn’t I have to pay that again at the end ...

After eight episodes of post-apocalypse insanity and plenty of irradiated creatures, Fallout wrapped up Season 2 with the season finale, “The Strip,” this week. Given that multiple characters are left ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

The “Run Away” ending has everyone talking. Harlan Coben’s eight-episode thriller, inspired by his 2019 novel of the same name, is riding high on Netflix’s streaming charts, second only to “Stranger ...

Minecraft is entering a new era in 2026. With the launch of Minecraft Java 26.1, Mojang is not just releasing another content patch — it’s introducing a new yearly versioning system and laying down ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

Joachim Trier goes deep into the silent ending of his Oscar contender, breaking down how he constructed a script that built toward such a powerful moment. “I’m out on a limb with this one,” said Trier ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...